RE: Oct 4th - Secret revealed.... I think you may be correct here Somewhey.
The question is how much thought will go into NOT mentioning Bioniche. For 2 reasons...Firstly no one south of the border could comprehend that the company that developed Urocidin and retains manufacturing rights and a transfer contract could only be valued at 44 mil. That would seem to be very odd math and probably embarassing to Endo, to be associated with such a small time operation, with so much at stake. Rather than have to explain to analyssts that their Canadian partner is perpetually "valuation and Communication Challenged" they are better off ignoring BNC entirely.
Secondly, with our chronically fatigued stock, they can buy us out with their annual exec golf costs. Why draw attention to the P ons who lucked into what they will ultimately own entirely.
All BNC could do is send some execs with sandwich boards to parade around outside the conference hall Chanting "What about Me and BNC"